Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Thomas Guzzo MD, MPH

Thomas J. Guzzo MD, MPH

Chief of Urology and Associate Program Director, University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania

Dr. Guzzo is Chief of Urology and Associate Program Director at the University of Pennsylvania. He is a graduate of Temple University School of Medicine. He completed his general surgery internship and urology residency at the Hospital of the University of Pennsylvania. Dr. Guzzo completed a fellowship at the James Buchanan Brady Urological Institute of the Johns Hopkins Hospital in urologic oncology. During his fellowship he also earned a Masters in Public Health from the Johns Hopkins Bloomberg School of Public Health. He is extensively trained in the treatment of all aspects of urologic malignancies including open, laparoscopic, endoscopic and robotic surgical treatment for such malignancies.

Dr. Guzzo’s clinical areas of expertise include the surgical treatment of prostate, bladder, kidney and testicular cancer. He has one of the largest urologic oncology practices in the region and specializes in open, endoscopic and minimally invasive surgical procedures. Additionally, he is a member of the Penn Academy of master clinicians.

Dr. Guzzo also maintains a productive urologic oncology research program. He is a Prostate Cancer Foundation young investigator award recipient. He is the director of the urologic oncology research laboratory at the University of Pennsylvania. He has published over 120 peer-reviewed manuscripts, over a dozen book chapters and is the editor of two text books in urology.

Disclosures

No disclosures to report.

Recent Contributions to PracticeUpdate:

  1. Natural History of Surgically Treated High-Risk Prostate Cancer
  2. Clinical Outcomes of cT1 Micropapillary Bladder Cancer
  3. Searching for the Optimal BCG Maintenance Regimen
  4. Evaluation of Reduced-Dose Bacillus Calmette-Guérin Maintenance Therapy
  5. Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
  6. Contemporary 90-Day Mortality Rates After Radical Cystectomy in the Elderly
  7. Leuprolide Plus Abiraterone More Effective in Prostate Cancer Than Abiraterone Alone
  8. PSA Helps Determine Whether to Treat or Watch After Radical Prostatectomy
  9. Perioperative Chemotherapy After RC Can Improve Cure Rates in Urothelial Carcinoma of the Bladder
  10. 2014 Top Stories in Urology: Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer

Most Read This Week

Recently Updated